PRODUCT MONOGRAPH. Pr TORADOL. ketorolac tromethamine 10 mg tablets. ketorolac tromethamine injection 10 mg/ml intramuscular injection

Similar documents
Accel-Celecoxib Product Monograph Page 52 of 56

PRODUCT MONOGRAPH. naproxen. 375 & 500 mg Enteric-Coated Tablet 750 mg Sustained-Release Tablet

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic

IMPORTANT: PLEASE READ

Sandoz Diclofenac and Sandoz Diclofenac SR Page 34 of 38

Sandoz Diclofenac and Sandoz Diclofenac SR Page 34 of 38

IMPORTANT: PLEASE READ

PART III: CONSUMER INFORMATION

PRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard

PRODUCT MONOGRAPH TARCEVA. erlotinib hydrochloride tablets. erlotinib 25, 100, 150 mg

PATIENT MEDICATION INFORMATION

PRODUCT MONOGRAPH. capecitabine. Tablets 150 mg and 500 mg. Manufacturer s Standard. Antineoplastic Agent. Date of Revision: February 10, 2017

LECTOPAM PRODUCT MONOGRAPH. bromazepam. 3 mg and 6 mg Tablets. Anxiolytic - Sedative. Date of Revision: September 6, 2018

IMPORTANT: PLEASE READ

PATIENT MEDICATION INFORMATION

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ALECENSARO. alectinib (as alectinib hydrochloride) Capsule, 150 mg

TORADOL Tablets contains the active ingredient ketorolac trometamol

PRODUCT MONOGRAPH. Pr PROLOPA. levodopa and benserazide capsules. 50 mg mg, 100 mg - 25 mg, 200 mg - 50mg. Pharmaceutical standard: professed

IMPORTANT: PLEASE READ

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. PRINIVIL (lisinopril tablets, Merck Standard)

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Buscopan Hyoscine Butylbromide Injection

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

in people who have heart disease

Non-steroidal Anti-Inflammatory Drugs (NSAIDs)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (omeprazole delayed release capsules USP)

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

Your doctor may have prescribed MOVALIS for another reason. Ask your doctor if you have any questions about why MOVALIS has been prescribed for you.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION LIPIDIL EZ. fenofibrate, NanoCrystal formulation tablets

Ask your healthcare provider if SPRIX (ketorolac tromethamine) Nasal Spray is right for you

OXEZE TURBUHALER formoterol fumarate dihydrate

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. rabeprazole sodium tablets

Patient Information Leaflet UNITED KINGDOM Feldene IM Intramuscular Injection 20mg/ml piroxicam

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. AZITHROMYCIN Azithromycin Tablets

PART III: CONSUMER INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PATIENT INFORMATION LEAFLET SINTAIR RANGE

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION

PART III: CONSUMER INFORMATION

PRODUCT MONOGRAPH. obinutuzumab. 25 mg/ml Concentrate for Solution for Infusion. Professed Standard. Antineoplastic

Read all of this leaflet carefully because it contains important information for you.

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. Pantoprazole Magnesium Enteric-Coated Tablets

It does not contain all the available information. It does not take the place of talking to your doctor or nurse.

RIVOTRIL PRODUCT MONOGRAPH. clonazepam. 0.5 mg and 2 mg Tablets. Anticonvulsant. Date of Revision: January 18, 2018

Migraine Relief Film-coated Tablets ibuprofen lysine

Advil* 200mg Tablets Ibuprofen

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ERYC Erythromycin delayed release capsules USP

IMPORTANT: PLEASE READ

PATIENT INFORMATION LEAFLET DYNARB RANGE

Patient Information Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg, 100 mg/12.5 mg and 100 mg/25 mg Rx only

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Methotrexate Injection USP Page 39 of 43

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ZEPATIER 50 mg of elbasvir and 100 mg of grazoprevir

MEDICATION GUIDE Prasugrel (pra-su-grel) tablets Read this Medication Guide before you start taking prasugrel and each time you get a refill.

Before you take CELECOXIB SANDOZ. When you must not take it

INFORMATION FOR THE CONSUMER

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ERLEADA apalutamide tablets

ONBREZ BREEZHALER should only be used to treat COPD.

ARTHREXIN indometacin

IMPORTANT: PLEASE READ

Before you take PROXEN SR. When you must not take it

Patient Information MICARDIS HCT (my-car-dis HCT) (telmisartan and hydrochlorothiazide) Tablets

PATIENT INFORMATION LEAFLET PEARINDA PLUS

Before you take Celebrex. When you must not take it

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

PRODUCT MONOGRAPH. Pr TAMIFLU. oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate)

Etopan XL 600 mg tablets

ALDACTAZIDE (spironolactone and hydrochlorothiazide) Page 33 of 37

OXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Palbociclib Capsules

Amizide contains the active ingredients hydrochlorothiazide and amiloride hydrochloride

PATIENT MEDICATION INFORMATION RAVICTI TM. (glycerol phenylbutyrate) Oral Liquid

Sandoz Lisinopril HCT Page 51 of 55

PROXEN SR contains the active ingredient naproxen

Package leaflet: Information for the patient. Melox 10 mg/ml solution for injection meloxicam

Irbenida H 150mg/12,5mg film-coated tablets

COMPOSITION: Each film-coated tablet contains 500mg mefenamic acid. Also includes sunset yellow E110. See leaflet for further information.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SABRIL (vigabatrin)

IMPORTANT: PLEASE READ

Medication Guide Plavix (PLAV-iks) (clopidogrel bisulfate) tablets

What is in this leaflet

Package Leaflet: Information for the User. Read all of this leaflet carefully because it contains important information for you.

It does not take the place of talking to your doctor or pharmacist.

IMPORTANT: PLEASE IMPORTANT: PLEASE IMPORTANT: PLEASE READ

Amlodipine and Celecoxib

Before you take ANAPROX. When you must not take it

Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

Full prescribing information is available to doctors and pharmacists on request.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

VOLTAREN. VOLTAREN Page 1 of 5

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

Ceclor CD cefaclor monohydrate sustained release tablets

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods.

Transcription:

PRODUCT MONOGRAPH Pr TORADOL ketorolac tromethamine 10 mg tablets Pr TORADOL IM ketorolac tromethamine injection 10 mg/ml intramuscular injection Non-Steroidal Anti-Inflammatory Drug (NSAID) Hoffmann-La Roche Limited 7070 Mississauga Road Mississauga, Ontario L5N 5M8 www.rochecanada.com Date of Revision: February 19, 2015 Copyright 1990-2015 by Hoffmann-La Roche Ltd. Submission Control No: 180668 TORADOL is a registered trade-mark of F. Hoffmann-La Roche AG, used under license. Page 1 of 6

Table of Contents PART III: CONSUMER INFORMATION...3 PART III: CONSUMER INFORMATION...3

PART III: CONSUMER INFORMATION Pr TORADOL ketorolac tromethamine tablets Pr TORADOL IM ketorolac tromethamine injection Read this information each time you refill your prescription in case new information has been added. This leaflet is part III of a three-part "Product Monograph" published when TORADOL was approved for sale in Canada and is designed specifically for Consumers. This leaflet is a summary designed specifically for you. It will not tell you everything about TORADOL. See your health care provider and pharmacist regularly and ask them questions about your health and any medications you take. ABOUT THIS MEDICATION What the medication is used for: Toradol Tablets Your health care provider has prescribed TORADOL tablets for you for one or more of the following medical conditions: for short-term use as pain relief after surgery, after labour or after injury causing muscle or joint pain (not to exceed 5 days for post-surgical patients or 7 days for patients with musculoskeletal pain) Toradol Intramuscular Injection Your health care provider has prescribed TORADOL IM for you for one or more of the following medical conditions: for short-term use in the hospital for pain relief after surgery (not to exceed 2 days) What it does: TORADOL (ketorolac tromethamine), as a non-steroidal antiinflammatory drug (NSAID), can reduce the chemicals produced by your body which cause pain and swelling. TORADOL, as a non-steroidal anti-inflammatory drug (NSAID), does NOT cure your illness or prevent it from getting worse. TORADOL only can relieve pain and reduce swelling as long as you continue to take it. When it should not be used: DO NOT TAKE TORADOL if you have any of the following medical conditions: have had or are planning to have heart bypass surgery have severe, uncontrolled heart failure have bleeding in the brain or other bleeding disorders are at 28 weeks of pregnancy or more are in labour and delivery are breastfeeding or planning to breastfeed are allergic to ASA (Acetylsalicylic Acid), other NSAIDs (Non-steroidal Anti-Inflammatory Drugs), TORADOL or its ingredients have active ulcer or bleeding from the stomach or gut have inflammatory bowel disease (Crohn s Disease or Ulcerative Colitis) have liver or kidney disease have high potassium in the blood are currently using probenecid or oxpentifylline are having central nervous system injection e.g. epidural, brain or spinal administration are going into have any major surgery are using other NSAIDs Patients who took a drug in the same class as TORADOL after a type of heart surgery (coronary artery bypass grafting (CABG)) were more likely to have heart attacks, strokes, blood clots in the leg(s) or lung(s), and infections or other complications than those who did NOT take that drug. TORADOL should NOT be used in patients under 18 years of age since the safety and effectiveness have NOT been established. What the medicinal ingredient is: ketorolac tromethamine What the non-medicinal ingredients are: TORADOL tablets: microcrystalline cellulose, lactose, magnesium stearate, hydroxy-propyl-methylcellulose, titanium dioxide, polyethylene glycol, edible black printing ink. TORADOL IM: 10% (w/v) alcohol, sodium chloride, sodium hydroxide, hydrochloric acid. What dosage forms it comes in: TORADOL is available as: tablets (10 mg) and solution for intramuscular injection (10 mg/ml). WARNINGS AND PRECAUTIONS If you have, or previously had, any of the following medical conditions, see your health care provider to discuss treatment options other than TORADOL: Heart Attack or Angina Stroke or Mini-stroke Loss of Vision Current Pregnancy (less than 28 weeks) Congestive Heart Failure Before taking this medication, tell your health care provider if you have any of the following: High blood pressure High cholesterol Diabetes mellitus or on a low sugar diet Thickening or hardening of your artery walls (Atherosclerosis) Poor circulation to your extremities Page 3 of 6

Smoker or ex-smoker Kidney disease or urine problems Previous ulcer or bleeding from the stomach or gut Previous bleeding in the brain Bleeding problems Liver, biliary, pancreatic or renal problems Family history of allergy to NSAIDs, such as acetylsalicylic acid (ASA), celecoxib, diclofenac, diflunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, indomethacin, ketoprofen, ketorolac, mefenamic acid, meloxicam, nabumetone, naproxen, oxaprozin, piroxicam, rofecoxib, sulindac, tenoxicam, tiaprofenic acid, tolmetin, or valdecoxib (NOT a complete list) Family history of asthma, nasal polyps, long-term swelling of the sinus (chronic sinusitis) or hives Family history of allergy to sulfonamide drugs (if applicable) Any other medical problem Also, before taking this medication, tell your health care provider if you are planning to get pregnant. While taking this medication: tell any other doctor, dentist, pharmacist or other health care professional that you see, that you are taking this medication, especially if you are planning to have heart surgery; do NOT drink alcoholic beverages while taking this medication because you would be more likely to develop stomach problems; fertility may be decreased. The use of TORADOL is not recommended in women trying to get pregnant. In women who have difficulty conceiving, stopping TORADOL should be considered. INTERACTIONS WITH THIS MEDICATION Talk to your health care provider and pharmacist if you are taking any other medication (prescription or non-prescription) such as any of the following (NOT a complete list): Acetylsalicylic Acid (ASA) or other NSAIDs e.g. ASA, celecoxib, diclofenac, ibuprofen, indomethacin, ketorolac, meloxicam, naproxen) Antacids Antidepressants Selective Serotonin Reuptake Inhibitors (SSRIs) e.g. citalopram, fluoxetine, paroxetine, sertraline Blood pressure medications ACE (angiotensin converting enzyme) inhibitors e.g. enalapril, lisinopril, perindopril, ramipril ARBs (angiotensin II receptor blockers) e.g. candesartan, irbesartan, losartan, valsartan Blood thinners e.g. warfarin, ASA, clopidogrel Corticosteroids (including glucocorticoids) e.g. prednisone Cyclosporin Digoxin Diuretics e.g. furosemide, hydrochlorothiazide Lithium Methotrexate Morphine Oxpentifylline Probenacid Your health care provider may prescribe low dose ASA (acetylsalicylic acid) as a blood thinner to reduce your risk of having a heart attack or stroke while you are taking TORADOL. Take only the amount of ASA prescribed by your health care provider. You are more likely to upset or damage your stomach if you take both TORADOL and ASA than if you took TORADOL alone. PROPER USE OF THIS MEDICATION TORADOL Tablets Usual dose (18-65 years of age): Medical Condition Post- Surgical Pain or postpartum uterine cramping pain Musculoskeletal Pain TORADOL IM Starting Dose 10 mg every 4 to 6 hours as required 10 mg every 4 to 6 hours as required Usual dose (18-65 years of age): Medical Condition Postsurgical or Musculoskeletal Pain Starting Dose Initial dose: 10 mg to 30 mg according to pain. Subsequent doses: 10 mg to 30 mg every 4 to 6 hours as needed to control pain Maximum Dose (per day) Doses exceeding 40 mg per day are not recommended Doses exceeding 40 mg per day are not recommended Maximum Dose (per day) Doses exceeding 120 mg per day are not recommended Maximum Duration of Treatment (days) 5 days 7 days Maximum Duration of Treatment (days) 2 days Take TORADOL only as directed by your health care provider. Do NOT take more of it, do NOT take it more often and do NOT take it for a longer period of time than your health care provider recommended. If possible, you should take the lowest dose of this medication for the shortest time period. Taking too much TORADOL may increase your chances of unwanted and sometimes dangerous side effects, especially if you Page 4 of 6

are elderly, have other diseases or take other medications. In general, TORADOL should not be used for more than 7 days. If a longer period is considered, see your health care provider regularly to discuss whether this medicine is working for you and if it is causing you any unwanted effects. This medication has been prescribed specifically for you. Do NOT give it to anyone else. It may harm them, even if their symptoms seem to be similar to yours. TORADOL is NOT recommended for use in patients under 18 years of age since safety and effectiveness have NOT been established. To lessen stomach upset, take TORADOL immediately after a meal or with food or milk. However, the presence of food in the stomach may delay the onset of pain relief. If stomach upset (indigestion, nausea, vomiting, stomach pain or diarrhea) occurs and continues, contact your doctor. You should remain standing or sitting upright (i.e. do not lie down) for about 15-30 minutes after taking the medicine. This helps to prevent irritation that may lead to trouble swallowing. Missed Dose: The missed dose should be taken as soon as remembered, and then the regular dosing schedule should be continued. Two doses of TORADOL should not be taken at the same time. Overdose: In case of drug overdose contact a health care practitioner, hospital emergency department, or regional Poison Control Centre immediately even if there are no symptoms. SIDE EFFECTS AND WHAT TO DO ABOUT THEM TORADOL may cause some side effects, especially when used for a long time or in large doses. When these side effects occur, you may require medical attention. Report all symptoms or side effects to your health care provider. TORADOL may cause you to become drowsy or tired. Be careful about driving or participating in activities that require you to be alert. If you become drowsy, dizzy or light-headed after taking TORADOL, do NOT drive or operate machinery. TORADOL may cause you to become more sensitive to sunlight. Any exposure to sunlight or sunlamps may cause sunburn, skin blisters, skin rash, redness, itching or discolouration, or vision changes. If you have a reaction from the sun, check with your health care provider. ALLERGIC REACTION to this medication. SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM Symptom STOP taking TORADOL and get emergency medical attention IMMEDIATELY STOP taking TORADOL and talk to your physician or pharmacist Bloody or black tarry stools Shortness of breath, wheezing, any trouble breathing or chest tightness Skin rash, hives, swelling or itching Blurred vision, or any visual disturbance Any change in the amount or colour of your urine (red or brown) Any pain or difficulty experienced while urinating Swelling of the feet, lower legs, weight gain Vomiting or persistent indigestion, nausea, stomach pain or diarrhea Yellow discolouration of the skin or eyes, with or without itchy skin Malaise, fatigue, loss of appetite Headaches, stiff neck Mental confusion, depression Dizziness, lightheadedness Hearing problems This is not a complete list of side effects. If you develop any other symptoms while taking TORADOL, see your health care provider. HOW TO STORE IT Store TORADOL at room temperature (15-30 o C) away from light. Do NOT keep outdated medicine or medicine no longer needed. Any outdated or unused medicine should be returned to your pharmacist Keep out of sight and reach of children. Check with your health care provider IMMEDIATELY if you develop chills, fever, muscle aches or pains, or other flu-like symptoms, especially if they occur before or together with a skin rash. These symptoms may be the first signs of a SERIOUS Page 5 of 6

REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways: -------------------------------------------------------------------------- Report online at www.healthcanada.gc.ca/medeffect Call toll-free at 1-866-234-2345 Complete a Canada Vigilance Reporting Form and: - Fax toll-free to 1-866-678-6789, or - Mail to: Canada Vigilance Program Health Canada Postal Locator 0701E Ottawa, Ontario K1A 0K9 Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect Canada Web site at www.healthcanada.gc.ca/medeffect. NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice. MORE INFORMATION This document plus the full product monograph, prepared for health professionals can be found at: www.rochecanada.com or by contacting the sponsor, Hoffmann-La Roche Limited, at: 1-888-762-4388 (Drug Information). This leaflet was prepared by Hoffmann-La Roche Limited. Last revised: February 19, 2015 Copyright 1990 2015 by Hoffmann-La Roche Ltd. TORADOL is a registered trade-mark of F. Hoffmann-La Roche AG, used under license. All other trade-marks are the property of their respective owners. Hoffmann-La Roche Limited Mississauga, Ontario L5N 5M8 Page 6 of 6